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a b s t r a c t
Measles virus (MV) is the causative agent of measles and its neurological complications, subacute
sclerosing panencephalitis (SSPE) and measles inclusion body encephalitis (MIBE). Biased hypermutation
in the M gene is a characteristic feature of SSPE and MIBE. To determine whether the M gene is the
preferred target of hypermutation, an additional transcriptional unit containing a humanized Renilla
reniformis green ﬂuorescent protein (hrGFP) gene was introduced into the IC323 MV genome, and nude
mice were inoculated intracerebrally with the virus. Biased hypermutation occurred in the M gene and
also in the hrGFP gene when it was inserted between the leader and the N gene, but not between the H
and L gene. These results indicate that biased hypermutation is usually found in a gene whose function is
not essential for viral proliferation in the brain and that the location of a gene in the MV genome can
affect its mutational frequency.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The measles virus (MV) belongs to the genus Morbillivirus of
the family Paramyxoviridae, and is a nonsegmented enveloped RNA
virus with negative polarity. The genome contains the N, P, M, F, H,
and L genes, from which are transcribed the mRNAs for the N
(nucleocapsid), P (phospho), M (matrix), F (fusion), H (hemagglu-
tinin), and L (large polymerase) proteins, respectively (Grifﬁn,
2013). The P gene also encodes the accessory V and C proteins,
which counter the host defense mechanisms (Ohno et al., 2004;
Palosaari et al., 2003; Shaffer et al., 2003; Takeuchi et al., 2003).
MV uses the signaling lymphocyte activation molecule (SLAM) as
the primary receptor to enter lymphatic cells (Erlenhoefer et al.,
2001; Hsu et al., 2001; Tatsuo et al., 2000) and uses nectin 4 to
enter epithelial cells (Mühlebach et al., 2011; Noyce et al., 2011).
MV vaccine and laboratory strains, including the Edmonston
strain, can also use CD46 (Hsu et al., 1998; Li and Qi, 2002;
Nielsen et al., 2001; Rima et al., 1997). Measles is caused by MV
infection and is a highly contagious disease. Although most people
recover within 2–3 weeks and measles can be prevented by
immunization, the disease can cause serious complications in
malnourished children and people with reduced immunity, in
whom it can be fatal. MV can also cause persistent neurological
complications when it infects the brain: subacute sclerosing
panencephalitis (SSPE) and measles inclusion body encephalitis
(MIBE).
SSPE is a disease of immunocompetent children or young adults
and develops 6–8 years after the recovery from measles experi-
enced at an early age, usually younger than two years old. MV has
been isolated from the brain cells of patients with SSPE by
cocultivation with cell lines susceptible to MV (Ogura et al., 1997).
Genetic analyses have revealed that the viruses derived from
patients with SSPE (“SSPE strains”) contain numerous mutations,
but several characteristic mutations occur in the genome (Ayata et
al., 1989; Baczko et al., 1993; Cattaneo et al., 1988a). In many SSPE
strains, clustered mutations occur in the genome, and destroy the
structure and/or function of the encoded proteins. This type of
mutation has been called “biased hypermutation”, and uracil-to-
cytosine (U-to-C, speciﬁed in the plus strand sense) mutations occur
most frequently in the M gene. Other characteristic changes in a
structural protein have been found in the F protein, preferentially
in its cytoplasmic tail (Billeter et al., 1994; Cattaneo et al., 1989;
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Ning et al., 2002; Schmid et al., 1992). Some of the mutations that
occur in this region can be explained by the mechanism that causes
biased hypermutation in the M gene (Cattaneo et al., 1989).
MIBE is primarily a disease of immunocompromised hosts,
including people with congenital immunodeﬁciency, acute leuke-
mia, or human immunodeﬁciency virus infection, and it typically
occurs several months after an acute measles infection. Genetic
analyses of the genomes of MVs from patients with MIBE have
shown mutations similar to those in the SSPE strains. Cattaneo
et al. reported biased hypermutation in the M gene of the MV
genome from a patient with MIBE (Cattaneo et al., 1988b), and a
virus isolated from a patient with MIBE showed a cell-associated
phenotype and neurovirulence in mice (Ohuchi et al., 1987). One
difference between SSPE and MIBE is that MIBE can be caused by
the MV vaccine strain (Bitnun et al., 1999).
To understand the mechanism of neurological infection by MV,
several animal model systems have been established. MVs gen-
erally do not induce neurological disease in small experimental
animals, probably because they lack high-afﬁnity MV receptors. In
contrast, the SSPE and MIBE strains show strong neurovirulence
and can induce lethal neurological disease in immunocompetent,
genetically unaltered rodents (Albrecht et al., 1977; Johnson and
Byington, 1971; Katz et al., 1970; Thormar et al., 1977, 1985; Sugita
et al., 1984). Ohuchi et al. reported a persistent infection in nude
mice induced with the intracerebral inoculation of the MV vaccine
strain (Ohuchi et al., 1984). The researchers inoculated nude
mice intracerebrally with 104 plaque-forming units (PFU) of the
Edmonston strain of MV, and the mice developed persistent and
ultimately lethal infections with long incubation periods of 2–5
months. This contrasted sharply with the SSPE Biken strain, which
caused signs of disease and death within 2 weeks. A sequence
analysis of the viral genome rescued from mice persistently
infected with the Edmonston strain revealed biased hypermuta-
tion (Abe et al., 2013). The authors also reported that the virus
rescued from a mouse caused neurological disease in nude mice
earlier than did its parental virus.
In the present study, we inoculated nude mice with recombi-
nant MV IC323, prepared from a plasmid containing the genome
of the wild-type IC-B strain (Takeda et al., 2000), to determine
whether wild-type MV can also establish a persistent infection in
nude mice. We found that MV IC323 was as neurovirulent in nude
mice as the Edmonston strain. Biased hypermutation occurred in
the viral genome during its persistent infection, most frequently in
the M gene, which is characteristic of SSPE and MIBE. Other
studies have shown that the M gene was not the only mutational
target when the host cellular enzyme adenosine deaminase acting
on RNA (ADAR) was involved in the mutation (Bass et al., 1989).
Results
Wild-type MV IC323 caused persistent infections in the brains of nude
mice and induced lethal encephalitis after long incubation
Five-week-old nude mice were inoculated in their right cere-
bral hemispheres with 500, 50, or 5 PFU of recombinant MV IC323
(n¼6 each group). The mice showed neurological signs and weight
loss after a long incubation and died (Fig. 1). The mice displayed
variable signs and sometimes died suddenly, although they had
looked healthy at most observation points. Based solely on their
neurological signs, including hyperactivity, jumping in response to
a sharp sound, involuntary body movements, and occasional
convulsive seizures, the incubation period of the mice inoculated
with 500 PFU of virus (99714 days) was signiﬁcantly shorter than
that of the mice inoculated with 50 PFU (2047116 days; Po0.05).
The period from the onset of signs to death varied from 2 to 61
days. The survival time of the mice inoculated with 500 PFU of
virus (126732 days) was signiﬁcantly shorter than that of
the mice inoculated with 50 PFU (2197116 days; Po0.05).
The incidence of neurological disease was 100% or 83% for mice
inoculated with 500 or 50 PFU of virus, respectively. (One mouse
inoculated with 500 PFU was omitted from the analysis because
it died with persistent diarrhea with no neurological signs).
No mouse inoculated with 5 PFU of virus showed any neurological
signs for 1 year. Thus, as the inoculum dose decreased, the inci-
dence of disease decreased and the incubation period became
longer. To test whether the nude mice showed age-based resis-
tance to MV infection, nude mice aged 8 weeks (n¼6) were also
inoculated with 500 PFU of virus. The mice showed similar but
rather insidious neurological signs and died at similar rates as the
mice inoculated at an age of 5 weeks. The incubation period was
94720 days and the survival time was 122751 days after
infection (Fig. 1). The differences in the incubation periods and
the survival times of the mice inoculated at 5 weeks and those
inoculated at 8 weeks were not signiﬁcant (P40.05).
Biased hypermutation occurred in the M gene, which is characteristic
of MV isolated from patients with SSPE or MIBE
We analyzed the viral RNAs extracted directly from brain
tissues and from selected mice using reverse-transcription (RT)–
PCR without cloning the PCR products into plasmids, and also
analyzed the viral RNAs extracted from rescued virus-infected cells
using RT–PCR. The viral RNAs from seven of 10 mice contained
clustered U-to-C (in the plus strand sense) mutations in the
genome, especially in the M gene (Fig. 2, Table 1). However, the
sites and the extents of the mutations varied considerably among
the mice (Fig. 2). Moreover, the viral genomes in their brains were
not homogeneous, and the sequencing electropherograms at many
mutated sites showed clear double peaks of the original U and
mutated C residues (U/C mixture, Y). Forty-four of 234 U residues
in the part of the genome corresponding to the open reading
frame encoding the M protein (1008 bases) were altered to C or Y
in the nude mouse designated “N1”. This mouse had a single G-to-
C mutation at this locus of the M gene, whereas no mutations were
found in the F or H gene. The mutations in the M gene of mouse
N1 theoretically resulted in 27 amino acid substitutions in the
coding region, and an elongation of 14 amino acids in the
cytoplasmic region of the protein was predicted to be caused by
Fig. 1. Survival analysis of nude mice after inoculation with the IC323 virus. Solid
lines with closed circles, squares, or triangles indicate mice inoculated with 500, 50,
or 5 PFU of virus, respectively, at the age of 5 weeks. The broken line with open
circles indicates mice inoculated with 500 PFU of virus at the age of 8 weeks.
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a mutation in the termination codon of the M gene. MVs from
other mice (N2, N4, N5, N11, N12, and N13) also contained
clustered U-to-C mutations in the M gene, with different frequen-
cies (Fig. 2, Table 1), whereas the clustered U-to-C mutations in the
P gene of MV from mouse N2 were exceptional (Table 1). Although
only single mutations were found in the M genes of mice N3, N9,
and N10 (Fig. 2, Table 1), all the mice examined contained some
mutation in the M gene. In contrast, no clustered mutations were
found in the F or H genes of MV in the mice examined, and only
single mutations were found in the F genes of mice N11 and N12.
Biased hypermutation can occur in any gene but only becomes
apparent when the mutation does not affect viral replication
To distinguish whether the M gene or some other speciﬁc
region of the genome is the preferred mutational target, an
additional transcriptional unit containing a humanized Renilla
reniformis green ﬂuorescent protein (hrGFP) gene was introduced
between the leader and the N gene or between the H and L genes
of the IC323 viral genome, and recombinant viruses were pre-
pared. The mice (n¼6 each) inoculated with these recombinant
viruses developed neurological signs 3–6 months later. The viral
RNAs were extracted from the brain tissues of the sacriﬁced mice
or prepared from cells infected with the rescued viruses. The PCR
products encoding hrGFP and other viral genes ampliﬁed from
these RNAs were subjected to sequence analysis without cloning
into plasmids. As expected, the M gene was frequently mutated
(mice N80, N82, N85, N89, and N90; Table 2). The hrGFP gene
inserted between the leader and the N gene also displayed biased
hypermutation, even more frequently than the M gene (mice N80–
N83, hrGFP in ldr-N; Table 2). Therefore, the cellular enzyme
involved can cause mutations in regions of the viral genome other
than the M gene. However, in contrast to the hrGFP gene inserted
between the leader and the N gene, the same hrGFP gene inserted
between the H and L genes remained intact (mice N85, N87, N89,
and N90, hrGFP in H-L; Table 2). These results indicate that the M
gene is not the preferred mutational target and that an addition-
ally introduced inessential gene near the 30 end of the MV genome
is most vulnerable to modiﬁcation. Sporadic mutations that
caused amino acid substitutions also occurred in the F gene
(Tables 2 and 3).
Discussion
The intracerebral inoculation of nude mice with MV IC323
caused persistent infections, and after a long incubation, the mice
showed neurological signs and ultimately died. This is consistent
with the previous report of nude mice inoculated with the
Edmonston strain (Abe et al., 2013; Ohuchi et al., 1984), and
indicates that the viral receptor usage in the central nervous
systems of mice (whether the virus uses CD46 or not) is irrelevant.
Fig. 2. Mutations in the M gene coding region. The number of mutations in the
gene encoding the M protein (1008 bases) was counted and plotted every 50
nucleotides. Mutations from U-to-C or U-to-Y (mixed sequence of U and C on the
electropherogram) are shown as black bars and the other types of mutations are
shown as gray bars.
Table 1
Mutations found in viral RNAs from the brains of nude mice persistently infected
with recombinant MV IC323.
Mouse ID N P M F H
N1 ND None U-to-Y: 44 None None
G-to-C: 1
N2 ND U-to-Y: 7 U-to-Y: 22 None None
A-to-G: 1
N3 ND None U-to-Y: 1 None None
N4 ND None U-to-Y: 6 None None
N5 ND None U-to-Y: 4 None ND
G-to-C: 1
N9 ND None C-to-U: 1 None ND
N10 ND None G-to-A: 1 None ND
N11 ND None U-to-Y: 3 G-to-A: 1 ND
N12 ND None U-to-Y: 7 A-to-G: 1 ND
N13 C-to-A: 1 C-to-U: 1 U-to-Y: 59 None None
A-to-G: 1
Numbers of mutations found in the genomes are shown. For mouse N13, the
sequence including nucleotides (nt) 94–9384 was determined. For the other mice,
the sequence of the gene encompassing the open reading frame was determined
(P: 1524 bases; M: 1008 bases; F: 1620 bases; H: 1854 bases). The PCR products
were sequenced without cloning them into plasmids. Y: U/C mixture. Mice N1–N5
were inoculated with 500 PFU of the IC323 virus at 5 weeks old, whereas N9–N13
were inoculated at 8 weeks old. ND: not determined.
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Viruses were rescued from the brains of these mice and a
sequence analysis revealed that the genomes contained clustered
U-to-C mutations almost exclusively in the M gene. This type of
mutation has been called “biased hypermutation” and was ﬁrst
discovered in the MV genome isolated from the brain of a patient
with MIBE (Cattaneo et al., 1988b). Among the genes of MV strains
isolated from the brain cells of patients with SSPE, biased hyper-
mutation has been most frequently and intensively found in the M
gene (Ayata et al., 1989; Cattaneo et al., 1989). The molecular
mechanism underlying these mutations has been attributed to the
host cellular enzyme ADAR (Bass et al., 1989). Of the three known
types of ADAR, ADAR1 is an interferon-inducible adenosine deami-
nase and catalyzes the C-6 deamination of A to inosine (I) in double-
stranded RNA substrates (George et al., 2011; Toth et al., 2006).
The mRNA with the mutation will then produce an aberrant viral
protein, because I is read as G. This A-to-I editing also alters the
structure of the affected protein because it can cause genetic
changes from A to G after viral replication when the I nucleotide
base pairs with C during antigenome synthesis, thus generating a
new genomic RNA. In relatively rare cases, A-to-G (speciﬁed in the
plus strand sense) mutations rather than U-to-C mutations have
been found in the M gene of the SSPE Osaka-3 strain (Ayata et al.,
1998b). Furthermore, 20 clustered A-to-G mutations were found in
the H gene of the IP-3-Ca strain of MV from a patient with SSPE
(Cattaneo et al., 1989). In these cases, mutations can be explained by
A-to-I conversion of an antigenomic plus strand. However, A-to-G
biased hypermutations were not found in the current model of
intracerebral MV infection in nude mice.
Because ADAR has broad speciﬁcity for RNA sequences (Wulff
and Nishikura, 2010), it can probably bind to and edit MV genes
other than the M gene. Indeed, we found mutations in the P gene
of an MV genome from mouse N2. Abe et al. also found mutations
in genes other than the M gene in nude mice persistently infected
with the Edmonston strain (Abe et al., 2013). However, viruses
with mutations affecting genes essential for viral replication
and spread would not survive easily. To obtain direct evidence
of whether the M gene is the preferred target of mutation, an
additional transcriptional unit containing the hrGFP gene was
introduced into the IC323 viral genome and whether the hrGFP
gene in the recombinant virus was mutated was determined.
Biased hypermutation occurred in the M gene of the virus and
also in the hrGFP gene at different frequencies. The hrGFP gene
inserted between the leader and the N gene was frequently
mutated, whereas the same gene inserted between the H and L
genes was not. Because ADAR recognizes double-stranded RNA as
its template, the nascent transcripts of hrGFP at the ﬁrst locus of
the virus genome may tend to form base-pairs with the template
viral genome (“collapsed transcription”, Bass et al., 1989), when
compared with those at the internal genome region between the H
and L gene. More abundant transcripts are produced from genes
near the 30 end of the MV genome, and a steep gradient of
transcripts was found in brain tissues (Cattaneo et al., 1987;
Schneider-Schaulies et al., 1989, 1999). It is possible that the N
gene is frequently mutated because it is located at the 30 end of the
natural MV genome and is most abundantly transcribed. However,
in the present study, we detected no mutations in the N gene.
Mutations in the N gene are unlikely ﬁxed in the virus genome,
because the N protein is essential for virus RNA synthesis. We
hypothesize that if ADAR affected essential genes, including N, the
mutated virus would not survive. It would then take the viral
population a long time to escape from this mutation and replicate
in the brain to induce clinically apparent encephalitis. This may
partly explain the long incubation period of the infection. It is
possible that biased hypermutation is observed only in genes or at
sites whose functions are not essential for viral growth or
proliferation in the brain. Whether ADAR affects the N gene
warrants further investigation and more sensitive methods may
be required to detect rare or short-lived products (Suspène et al.,
2008). Unlike the N gene, the M gene is not considered to be an
Table 3
Predicted amino acid substitutions in the F protein
of recombinant MVs in the brains of persistently
infected nude mice.
Mouse ID Substitution
N11 G290R
N80 G253E
N81 P224S
N82 N183D
N85 I172T
Y209H
L256S
N89 Y209H
D241N
N90 I98T
R469E
G534S
Table 2
Mutations found in the viral RNAs from the brains of nude mice persistently
infected with recombinant MV IC323 containing the hrGFP gene.
Mouse
ID
hrGFP N M F H hrGFP
in ldr-N in
H-L
N80 U-to-Y: 36 None U-to-Y: 135 G-to-R: 1 None –
[31.0%] [57.9%]
(U-to-Y: 4) (U-to-Y:
8)
N81 U-to-Y: 43 None A-to-G: 1 C-to-U:1 None –
[37.1%]
(U-to-Y: 4)
G-to-K: 2
N82 U-to-Y: 59 None A-to-R: 1 None –
[50.9%] U-to-Y: 4
(U-to-Y: 10) [1.7%]
A-to-C: 1
N83 U-to-Y: 84 None None None None –
[72.4%]
(U-to-Y:
10)
N85 – None U-to-Y: 3 U-to-Y: 3 None None
[1.3%]
(U-to-Y:
5)
N87 – None U-to-Y: 1 None None None
[0.4%]
N89 – None U-to-Y: 27 U-to-Y: 1 None None
[11.6%] G-to-R:
1
N90 – None U-to-Y: 59 U-to-Y: 1 None None
[25.3%] A-to-R:
1
(C-to-M:
1)
(U-to-Y: 8) G-to-R:
1
Numbers of mutations found in the genomes are shown. Sequences of the open
reading frames and the noncoding regions (shown in the parentheses) were
determined. The PCR products were sequenced without cloning them into
plasmids. Y: U/C mixture; R: A/G mixture; K: U/G mixture; M: C/A mixture. The
percentages of changes from U to Y are shown in brackets. Five-week-old nude
mice were inoculated with 870 PFU of the IC/ldr-hrGFP-N virus (mice N80–N83) or
840 PFU of the IC/H-hrGFP-L virus (mice N85–N90).
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essential gene in vitro; nor is it required for viral persistence in the
brain. Therefore, any mutation of the M gene is permitted. Because
biased hypermutation occurred frequently and reproducibly in
the hrGFP gene inserted between the leader and the N gene in the
MV genome of recombinant-MV-infected nude mice, this model
should provide a good in vivo system for understanding the
molecular mechanism of mutation by ADAR and to verify the
clonal expansion of mutated MV in the brain (Baczko et al., 1993).
Several studies have reported the role of ADAR during MV
replication. Toth et al. described antiapoptotic and proviral roles
for ADAR1 during MV infection (Toth et al., 2009). In contrast, Ward
et al. demonstrated an antiviral role for ADAR1 during MV infection
(Ward et al., 2011). Although the proactive role of the hypermutation
of the M gene in MV replication is not yet understood, it is
interesting to speculate that the inactivation of the M protein
function is preferred during the early stage of infection. The
presence of ADAR can reduce the amount of functional M protein
and direct optimal transcription and replication in the early stage of
infection. When the M protein accumulates after its translation from
unedited M mRNA in the late stage, the M protein will inhibit RNA
synthesis and act in viral assembly and budding. Further studies are
required to understand the possible involvement of ADAR in the
switching between MV replication and assembly.
In the current model of intracerebral infection with wild-type
MV in nude mice, lethal infection was induced after long persis-
tence, and biased hypermutation events were frequently observed.
This model will be useful for understanding the pathogenesis of
MIBE. It is possible that the rescued viruses were highly neuro-
virulent variants that appeared in the brain during persistent
infection. Abe et al. reported that the virus rescued from nude
mice inoculated with the Edmonston strain induced neurological
disease with a reduced incubation period (Abe et al., 2013).
However, the incubation period of the disease required by that
rescued virus was much longer than that required by SSPE strains.
Our preliminary results show that the biased hypermutation
observed in the genomes of viruses rescued from mice did not
correlate directly with higher MV neurovirulence in mice, because
mice inoculated with the rescued viruses developed persistent
infections and showed neurological signs only several months later.
This is consistent with the results obtained with recombinant MV
IC323 containing the M gene from an SSPE strain, which was not
neurovirulent in hamsters (Ayata et al., 2010). This is in sharp
contrast to the results for mice or hamsters inoculated with the
SSPE Biken or Osaka-2 strain, which caused acute encephalitis
within 2 weeks (Ayata et al., 2010; Ohuchi et al., 1984; Sugita et
al., 1984), as was also shown by Abe et al. with the SSPE Yamagata-1
strain in nude mice (Abe et al., 2013). Therefore, biased hypermuta-
tion may not necessarily be required for the acquisition of neuro-
virulence. It should be noted that some mice displayed no biased
hypermutation (mice N3, N9, and N10; Fig. 1 and Table 1), and no
preferred regions were targeted (mice N1, N2, N4, N5, N11, N12, and
N13; Fig. 1 and Table 1), suggesting that the inoculated MV itself has
the potential to replicate and induce encephalitis in the brains of
nude mice. Recently, we demonstrated a relationship between
amino acid substitutions in the extracellular domain of the F protein
and neurovirulence in hamsters (Ayata et al., 2010). We have also
demonstrated that amino acid substitutions in the H protein con-
tribute to MV neurovirulence in hamsters (Ayata et al., 2010; Ayata,
unpublished observation). Although no sequence information on the
F and H genes of that rescued virus was reported by Abe et al.
(Abe et al., 2013), we cannot exclude the possibility that mutations
that enhanceMV neurovirulence appear in the F or H gene during its
persistence in mice.
Conclusions
Wild-type MV caused persistent infections in the brains of
nude mice and induced lethal encephalitis after long incubation.
Biased hypermutation occurred in the M gene and also in the
hrGFP gene when it was inserted between the leader and the N
gene, but not when it was inserted between the H and L genes,
indicating that the location of a gene in the MV genome can affect
its mutational frequency.
Materials and methods
Cells and viruses
B95a cells were cultured in RPMI-1640 (Nissui Pharmaceutical
Co., Tokyo, Japan) supplemented with 10% heat-inactivated fetal
calf serum (FCS). BSRT7/3 cells were cultured in Dulbecco's
modiﬁed Eagle's medium (Nissui Pharmaceutical Co.) supplemen-
ted with 5% FCS.
Cell-free recombinant MV was obtained by freeze–thawing and
centrifugation at 1600g at 4 1C, and was stored at –85 1C. The
infective titer of the viral stock was determined by counting the
PFU in B95a cells.
Plasmids and preparation of recombinant viruses
Recombinant MV IC323 was generated from the p(þ)MV323
plasmid (Takeda et al., 2000) using CHO/SLAM cells and vaccinia
virus carrying a T7 RNA polymerase, vTF7–3 (Ayata et al., 2010).
A gene encoding hrGFP prepared from the phrGFP-1 vector
(Agilent Technologies, Santa Clara, CA, USA) was introduced either
between the leader and the N gene or between the H and L genes
to produce plasmids p(þ)MV323/ldr-hrGFP-N or p(þ)MV323/H-
hrGFP-L, respectively (Fig. 3). To construct p(þ)MV323/ldr-hrGFP-
N, the hrGFP gene was inserted after the start sequence of the N
gene, and the gene end and start signals for the N–P junction were
added downstream from the hrGFP gene. To construct p(þ)
MV323/H-hrGFP-L, the N gene end sequence was added after the
H gene, followed by the junction trinucleotides and the region
Fig. 3. Schematic diagram of plasmid insets encoding recombinant viruses pMV
(þ)323/ldr-hrGFP-N (A) and pMV(þ)323/H-hrGFP-L (B). The six protein-coding
regions (N, P, M, F, H, and L) are indicated. The hrGFP gene (770-bp fragment
prepared from the plasmid phrGFP-1, corresponding to nucleotide positions 678–
1457) was inserted between either the leader and the N gene (A) or between the H
and L genes (B). The numbers above the nucleotide sequence indicate the positions
in the MV genome of the parental plasmid pMV323(þ) (Takeda et al., 2000).
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including the N gene start sequence, and the N gene end sequence
and junction trinucleotide were then added downstream from the
hrGFP gene.
To prepare p(þ)MV323/ldr-hrGFP-N, plasmid p(þ)MV323 was
digested with BssHII and BstEII and the large (MV323/BssBst-Vec)
and small (MV323/BssBst-Frag) fragments were isolated and
puriﬁed with a gel extraction kit (Qiagen, Hilden, Germany). Using
MV323/BssBst-Frag as the template, fragment A was ampliﬁed
by polymerase chain reaction (PCR) with primers MVhrGFP-1 (50-
CGCCAAGCGCGCCAGTGAATTGTAATAC-30) and MVhrGFP-2 (50-
ATCCGCCCGGGCTATCCCTAATCCT-30). Using the phrGFP-1 plasmid
as the template, fragment B was ampliﬁed by PCR with primers
MVhrGFP-3 (50-ATTAGGGATAGCCCGGGCGGATCC-30) and MVhr-
GFP-4 (50-ACCTGGTTCCTAAGTTTTTTATAACTCGAGGTCGACG-30).
Using fragments A and B as templates, fragment C was ampliﬁed
by PCR with primers MVhrGFP-1 and MVhrGFP-5 (50-
GGATGTTGGTTGGCTGGCGGCTGTGTGGACCTGGTTC-30). Using MV-
323/BssBst-Frag as the template, fragment D was ampliﬁed by
PCR with primers MVhrGFP-6 (50-AACCAACATCCGAGATGGC-
CACACTTTTGA-30) and MVhrGFP-7 (50-CGGTTGGGTCACCTCGGT-
CGCTTGTG-30). Using fragment C as the template, fragment E
was ampliﬁed by PCR with primers MVhrGFP-1 and MVhrGFP-8
(50-AGCTCCTCAAAAGTGTGGCCATCTCGGATGTTGGTTG-30). Finally,
using fragments D and E as templates, fragment F was ampliﬁed
by PCR with MVhrGFP-1 and MVhrGFP-7, and was digested with
BssHII and BstEII. The resulting fragment was ligated into the
vector fragment MV323/BssBst-Vec, the plasmids were screened,
and p(þ)MV323/ldr-hrGFP-N (clone pMA03126) was obtained. To
prepare p(þ)MV323/H-hrGFP-L, plasmid p(þ)MV323 was
digested with SpeI and AﬂII and the large fragment (MV323/
SpeAﬂ-Vec) was isolated. Using plasmid pMA03126 as the tem-
plate, fragment G was ampliﬁed by PCR with primers MVhrGFP-1
and MVhrGFP-4. Using fragment G as the template, fragment H
was ampliﬁed by PCR with primers MVinHnL-A (50-CCACTAGTGT-
GAAATGTTATAAAAAACTTAGGATTCAAGATC-30) and MVinHnL-B
(50-GGAAACCACTTGGACCCTAAGTTTTTTATAACTC-30). Using plas-
mid pMA03126 as the template, fragment I was ampliﬁed with
primers MVinHnL-C (50-CTTAGGGTCCAAGTGGTTTCC-30) and
MVinHnL-D (50-CGTTTCTTAAGGTTGTAATGCCATGTGCTG-30). Using
fragments H and I as the templates, fragment J was ampliﬁed by
PCR with primers MVinHnL-A and MVinHnL-D, and was digested
with SpeI and AﬂII. The fragment was ligated into MV323/SpeAﬂ-
Vec, the plasmid was screened, and p(þ)MV323/H-hrGFP-L (clone
pMA09135) was obtained. Recombinant viruses were prepared
with the vaccinia-virus-free method, as previously described (Seki
et al., 2011), with some modiﬁcations. In this study, we used the
BSRT7/3 cell line instead of the BHK/T7-9 cell line to constitutively
express T7 RNA polymerase. All recombinant MVs were propa-
gated and titrated in B95a cells. We found a single cytosine-to-
adenine (C-to-A) mutation in the H gene of the IC/ldr-hrGFP-N
virus and a single A-to-G mutation in the N gene of the IC/H-
hrGFP-L virus, which appeared during the preparation of the virus.
Virus inoculation into and recovery from mice
Five- or eight-week-old female nude mice (BALB/c-nu/nu; CLEA
Japan, Tokyo, Japan) were gently anesthetized with sevoﬂurane
and their right cerebral hemispheres inoculated with 30 μL of
appropriately diluted viral stock. Selected mice from each group
were sacriﬁced in the terminal stage of the disease; their brains
were removed and subjected to virus rescue. The viruses were
recovered from the brain cells by cocultivation with B95a cells. The
log-rank test was used for the statistical analysis of the survival
curves. All animal experiments were performed according to the
Guide for Animal Experimentation, Osaka City University, in an
isolation area for infected animals at the BSL-2 level in the
Laboratory Center of the Medical School, Osaka City University.
RNA preparation and RT–PCR
Total cellular RNA was extracted from the recovered virus-
infected cells or directly from the brains, according to the pre-
viously described method (Ayata et al., 1998a). The RNA was
reverse transcribed with a random nonamer (Takara Bio Inc., Otsu,
Japan). Overlapping regions containing the N, P, M, F, H, or hrGFP
genes were ampliﬁed by PCR with gene-speciﬁc primer pairs and
directly sequenced, as previously described (Ayata et al., 2010). The
mixture of nucleotides in the sequencing electropherogram was
judged by the appearance of clear double peaks. At least 10% of
populations were necessary to show a mixed nucleotide in the
sequencing electropherogram as shown by (Takeda et al., 2002).
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